Acme United (ACU) Q4 2022: First Aid Revenues Hit 55% of Total, Cost Actions Target $5M in Savings
Acme United’s Q4 revealed margin compression from supply chain and inflation, but the company’s first aid and medical segment now drives over half of total revenue, anchoring its business model shift. Strategic cost reductions and inventory normalization are set to restore profitability, while management eyes further first aid vertical integration. Investors should watch for execution on cost savings and demand normalization at retail partners as key levers for 2023.
Summary
- First Aid Dominance: First aid and medical now comprise the majority of Acme’s revenue base.
- Cost Structure Reset: $5 million in targeted cost savings and inventory reductions to support margin recovery.
- Profitability Focus: Execution on cost actions and demand normalization at retailers will determine 2023 trajectory.
Business Overview
Acme United is a supplier of cutting, measuring, and safety products, with a portfolio that includes Westcott, Camillus, CUDA, First Aid Only, and SafetyMate. The company’s business model centers on manufacturing and distributing branded office, school, industrial, and first aid products, with an increasing focus on first aid and medical supplies—now over 55 percent of sales. Revenue is generated through retail, industrial, and commercial distribution channels across the US, Canada, and Europe.
Performance Analysis
Q4 2022 saw Acme United’s revenue decline modestly due to broad-based inventory reductions by major retail customers in the US and Canada, despite underlying consumer demand remaining resilient. The company’s annual revenue reached a new record, but net income dropped sharply as over $4 million in unpassed supply chain and freight costs pressured margins. Gross margin contracted to 32 percent for the quarter, down from 35.1 percent, reflecting higher ocean freight, port fees, and unfavorable currency impacts in Europe and Canada, where inventory is sourced in US dollars.
SG&A expenses rose as a percentage of sales, reflecting inflationary wage pressures and higher operating costs. Interest expense also increased due to higher debt levels and rising rates, further impacting bottom-line results. Inventory was built up in anticipation of supply chain disruptions, but management began reducing inventory late in the year, with a plan to lower it by another $5 million in 2023 to generate cash flow and reduce debt.
- First Aid Drives Growth: First aid and medical products accounted for 55 percent of 2022 sales, up from 50 percent in 2021, signaling a business model pivot.
- Retail Headwinds: Major retailers’ inventory drawdowns weighed on Q4 sales, but underlying product turns remained stable.
- Cost Pressure: Ocean freight, port fees, and FX headwinds drove sharp margin compression, with $4 million in extra supply chain costs not passed to customers.
Despite these pressures, Acme expanded its product lines and completed two acquisitions, positioning itself for improved profitability as cost actions and supply chain normalization take effect.
Executive Commentary
"Despite these issues, We had net sales in 2022 of $193.9 million, compared to $182.1 million in 2021, an increase of 7%. This was the 13th consecutive year of record sales. Our net income was impacted by the increased costs. In particular, we had over $4 million of extra expenses in container costs, port demurrage fees, and drayage, which we did not pass to customers."
Walter C. Johnson, Chairman and CEO
"The decline in both periods was primarily due to higher ocean freight and related transportation costs for imported goods. Also contributing to decline were weaker currencies in Europe and Canada where we purchased most of our inventory in U.S. dollars."
Paul Driscoll, Chief Financial Officer
Strategic Positioning
1. First Aid and Medical as Core Growth Engine
First aid and medical products now represent the majority of Acme’s sales, up to 55 percent in 2022. This category’s annuity-like refill business and expansion into industrial and retail channels provide a more stable and recurring revenue base. The company continues to invest in product innovation and distribution expansion, including the integration of MedNap and the acquisition of SafetyMate and ReadyFor kits.
2. Margin Recovery Through Cost Actions
Management is executing a $5 million cost reduction plan for 2023, targeting both cost of goods (60 percent) and SG&A (40 percent). These actions include improved production efficiency, lower transportation costs, and tighter SG&A controls, aiming to restore margins after a year of supply chain-driven cost spikes.
3. Inventory and Cash Flow Management
Inventory reduction is a top priority, with a $5 million decrease planned to free up cash and reduce debt. This reflects a shift from pandemic-driven inventory builds to a more normalized supply chain environment, supporting future acquisition capacity and financial flexibility.
4. Selective M&A as a Strategic Lever
Acme’s acquisition strategy remains focused on vertical integration in first aid and medical, with self-generated deal sourcing. Management does not expect geographic expansion but is actively pursuing tuck-in deals and competitor acquisitions in its core categories, particularly in the back half of 2023.
5. Product Innovation and Brand Expansion
Westcott, Camillus, and CUDA brands continue to expand with new product introductions and channel wins. The company remains the largest global supplier of scissors and is leveraging its brand equity to drive incremental growth in both legacy and emerging categories.
Key Considerations
Acme United’s 2022 performance reflects a business in transition, balancing short-term margin pressure with long-term growth investments in first aid and medical. The company is betting on cost discipline and inventory normalization to restore profitability, while using M&A and innovation to deepen its moat in core categories.
Key Considerations:
- First Aid’s Recurring Revenue Profile: The refill and replenishment model in first aid cabinets creates a growing annuity stream, supporting more predictable cash flow.
- Retail Inventory Dynamics: Continued inventory drawdowns at key retail partners could create near-term sales volatility, but management expects normalization soon.
- Cost Action Execution: Realization of the $5 million in cost savings is critical for margin recovery and debt reduction in 2023.
- M&A Pipeline: Vertical integration and competitor acquisitions in first aid remain a strategic focus, but timing is weighted to late 2023.
Risks
Margin recovery is contingent on successful execution of cost reductions and normalization of retail inventory levels. Persistent inflation, further supply chain disruptions, or a slower-than-expected rebound in retail orders could pressure both top line and profitability. Rising interest rates and higher debt levels increase financial risk, and currency fluctuations remain a headwind in international markets. Management’s decision not to provide formal 2023 guidance underscores ongoing macro uncertainty.
Forward Outlook
For Q1 and Q2 2023, Acme United expects:
- Solid performance, with profitability recovery as cost savings materialize.
- Inventory reductions of $5 million to support cash flow and debt paydown.
For full-year 2023, management did not provide formal guidance but stated:
- Forecasting growth over 2022 with “much improved profitability” as supply chain costs abate and cost actions take hold.
Management highlighted several factors that will shape near-term results:
- Retail customer inventory normalization is expected to be largely complete early in the year.
- Cost reductions and lower container rates are expected to drive margin improvement.
Takeaways
Acme United’s 2022 results underscore the company’s pivot to first aid and medical as its core business, while margin headwinds from supply chain and inflation dominated the year. The company is positioned to benefit from cost actions and inventory normalization, but execution and demand trends at retail partners remain key watchpoints.
- First Aid’s Share of Sales: With over half of revenue now from first aid, Acme’s business model is more resilient and recurring, but concentrated in one segment.
- Margin Recovery Hinges on Cost Actions: Execution on $5 million in cost savings and inventory reduction will determine the pace of profitability rebound.
- M&A and Innovation Remain Levers: Vertical integration in first aid and continued product innovation are central to Acme’s long-term growth strategy.
Conclusion
Acme United exited 2022 with a more focused, first aid-centric business model, but faces the challenge of restoring profitability amid persistent macro headwinds. The company’s cost actions and inventory normalization provide a credible path to improved results, but execution and retail demand trends will be decisive in 2023.
Industry Read-Through
Acme United’s experience highlights the sector-wide impact of supply chain and inflationary pressures on branded consumer products companies, particularly those reliant on global sourcing and retail distribution. The shift toward annuity-like revenue streams in first aid and medical underscores a broader industry move to recurring models for stability. Retail inventory management remains a key variable for suppliers, and those able to flex production, manage working capital, and execute on cost discipline will be best positioned for recovery. The emphasis on vertical integration and self-sourced M&A also reflects a trend toward control and margin protection in fragmented categories.